Heart attack at off-hours and weekend linked to higher risk of death
A study showed that patients who arrive at a hospital during off-hours and on the weekend following a heart attack have longer times to the restoration of normal blood flow and a higher risk of death.
Reperfusion therapy with either fibrinolytic therapy or percutaneous coronary intervention ( PCI ) reduces the risk of death for eligible ST-segment elevation myocardial infarction ( STEMI ) patients. The shorter the time from symptom onset to treatment, the greater the survival benefit with either therapy.
David J. Magid, of Kaiser Permanente, Denver, and colleagues examined the relationship between time of day and day of week and reperfusion treatment times for STEMI patients treated with fibrinolytic therapy or PCI.
. The study included 68,439 patients with STEMI treated with fibrinolytic therapy and 33,647 treated with PCI from 1999 through 2002. The researchers classified patient hospital arrival period into regular hours ( weekdays, 7 a.m.-5 p.m. ) and off-hours ( weekdays 5 p.m.-7 a.m. and weekends ).
The researchers found that most fibrinolytic therapy ( 67.9 percent ) and PCI patients ( 54.2 percent ) were treated during off-hours.
Door-to-drug times ( the time from arriving at the hospital to receiving blood-clot dissolving medications ) were slightly longer during off-hours ( 34.3 minutes ) than regular hours ( 33.2 minutes; difference, 1.0 minute ).
In contrast, door-to-balloon times ( the time from arriving at the hospital to receiving PCI ) were substantially longer during off-hours ( 116.1 minutes ) than regular hours ( 94.8 minutes; difference, 21.3 minutes ).
A lower percentage of patients met guideline recommended times for door-to-balloon during off-hours ( 26 percent ) than regular hours ( 47 percent ).
Door-to-balloon times exceeding 120 minutes occurred much more commonly during off-hours ( 42 percent ) than regular hours ( 28 percent ).
Longer off-hours door-to-balloon times were primarily due to a longer interval between obtaining the electrocardiogram and patient arrival at the catheterization laboratory ( off-hours 69.8 minutes vs. regular hours 49.1 minutes ).
This pattern was consistent across all hospital subgroups examined.
Patients arriving during off-hours had significantly higher adjusted in-hospital death rates than patients arriving during regular hours. This mortality difference was reduced by 43 percent when researchers adjusted for differences in reperfusion treatment times, suggesting that the higher off-hours mortality was due in part to longer reperfusion treatment times.
The researchers add that this study demonstrates that delays to PCI during off-hours are common to all types of hospitals, including high-volume PCI centers.
“ Our study has implications for the delivery of reperfusion therapy during off-hours. Because delays to PCI can result in lower survival rates for STEMI patients, institutions providing PCI during off-hours should commit to doing so in a timely manner. One way to improve the timeliness of PCI during off-hours would be to provide onsite staffing of the cardiac catheterization laboratory around-the-clock. However, the clinical benefits of providing continuous in-house staffing of the cardiac catheterization laboratory must be weighed against the extra cost of providing such coverage,” the researchers write.
“Another possible solution is to cross-train noncardiac catheterization laboratory staff to assist with PCI during off-hours. However, the benefits of cross-training staff may not be realized unless rapid access to interventional cardiologists is also available. Still another approach would be to regionalize interventional cardiac care, transporting off-hour patients to institutions with continuous cardiac catheterization laboratory staffing and rapid door-to-balloon times. However, this approach would only affect patients transported by emergency medical services and the faster door-to-balloon times at regional centers might be offset by prolonged transport times to these hospitals,” the authors write.
Source: American Medical Association, 2005
XagenaMedicine2005